FPMAJ, JPMA Issue Joint Statement on Emergency Price Cut for Opdivo

November 17, 2016
The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) and the Japan Pharmaceutical Manufacturers Association (JPMA) on November 16 issued a joint statement on the emergency NHI price reduction of Opdivo (nivolumab), which was given the nod by the Central...read more